Drug Discovery and Development Seminar

Tue, 10/23/2018 - 4:00pm

TOPIC: "Design and Discovery of Probes and/or Potential Therapeutic Lead Compounds for Cancer, Ischemia-Reperfusion Injury, HIV/AIDS, or Mitochondrial Protection"
SPEAKER: John K. Buolamwini, PhD | Chair and Professor, Department of Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science

Tuesday, Oct. 23, 2018
4 p.m.
College of Pharmacy, Skaggs Building, Room 325

About Dr. John K. Buolamwini
My laboratory is involved in small molecule drug/probe design and discovery research. The talk will highlight the use of computer-aided drug design, chemical synthesis and biological studies to discover and optimize potential drug lead compounds and/or probes targeting EGFR, MDM2 and STAT3 for cancer, nucleoside transporters for ischemia–reperfusion injury and protection of mitochondrial from drug toxicity, and HIV integrase for HIV/AIDS. An interdisciplinary approach has been applied to the identification of small molecules with potential therapeutic leads and/or the development of pharmacological tools for difficult-to-treat cancers such as pancreatic cancer, triple negative breast cancer, and melanoma, as well as ischemic heart disease, HIV/AIDS, and mitochondrial rescue.

Host: Jun Wang

For future seminars, please go to:
http://www.pharmacy.arizona.edu/academics/graduate-programs/seminars

Contact: David Bishop at bishop@pharmacy.arizona.edu

View, post and share the flyer for this event:
Buolamwini_CV (2).pdf

University of Arizona College of Pharmacy
Skaggs Building, Room 325

1295 N Martin Ave, Tucson, AZ 85721